Alternaria Tenuis
Payments companies reported to CMS as associated with Alternaria Tenuis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Alternaria Tenuis, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Alternaria Tenuis
These are the largest totals companies reported as associated with Alternaria Tenuis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Prasad Nataraj | Bel Air, MD | Allergy & Immunology | $255.95 |
| Lara Gross | Dallas, TX | Allergy & Immunology | $138.58 |
| Haylee Hauser | Southlake, TX | $116.57 | |
| Michele Johnson-Towson | Tampa, FL | Pediatrics | $101.42 |
| Brian Stansell | Birmingham, AL | Pediatrics | $101.42 |
| Sally Bailey | Baltimore, MD | Allergy & Immunology (Internal Medicine) | $101.42 |
| Sarah Heinonen | Los Angeles, CA | Pediatrics (Nurse Practitioner) | $101.42 |
| Janesri De Silva | Mission Hills, CA | Pediatrics | $101.42 |
| David Fitzhugh | Chapel Hill, NC | Allergy & Immunology | $101.42 |
| Erin Tomlin | Shaw Afb, SC | Pediatrics | $101.40 |
Prescribed Alternaria Tenuis?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.